Advertisement
Joining Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical, Inc.,will be Stanley Hao, Chief Financial Officer. The Company plans to issue anearnings announcement prior to the call.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: 1 888419 5570. International callers should dial +1 617 896 9871. The Conference IDfor this call is 814 194 70.
If you are unable to participate in the call at this time, a replay willbe available for fourteen days starting on Tuesday, November 17, 2009 at 10:00a.m. Eastern Standard Time. To access the replay, dial 888 286 8010,international callers dial 617 801 6888. The Conference Replay Passcode is 254153 02.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company.The Company engages in the manufacturing, marketing and distribution ofpharmaceutical, medicinal and diagnostic products. Through its wholly-ownedsubsidiaries, Harbin Tian Di Ren Medical Science and Technology Company("TDR"), Harbin First Bio- Engineering Company Limited ("First"), HeilongjiangTianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin ChuangPharmaceutical Company ("Jin Chuang") the Company manufactures and distributesover-the-counter pharmaceutical products, which make up its major revenuesource. For more information, visit http://www.skyonemedical.com.
Safe Harbor Statement
Certain of the statements made in the press release constituteforward-looking statements within the meaning of the Private SecuritiesLitigation Reform Act of 1995. These statements can be identified by the useof forward- looking terminology such as "believe," "expect," "may," "will,""should," "project," "plan," "seek," "intend," or "anticipate" or the negativethereof or comparable terminology. Such statements typically involve risks anduncertainties and may include financial projections or information regardingthe change of independent directors. Actual results could differ materiallyfrom the expectations reflected in such forward-looking statements as a resultof a variety of factors, including the risks associated with the effect ofchanging economic conditions in The People's Republic of China, variations incash flow, reliance on collaborative retail partners and on new productdevelopment, variations in new product development, risks associated withrapid technological change, and the potential of introduced or undetectedflaws and defects in products, and other risk factors detailed in reportsfiled with the Securities and Exchange Commission from time to time.For more information, please contact: Company Contact: China Sky One Medical, Inc. Mr. Yu-Bo Hao, CFO Tel: +86-451-5399-4069 Email: [email protected] Investor Relations Contact: CCG Investor Relations Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: [email protected] Website: http://www.ccgirasia.com
SOURCE China Sky One Medical, Inc.
